Characteristics of West Nile encephalitis in the Autonomous Province of Vojvodina in the period 2021 to 2022

Introduction. Neuroinvasive the West Nile virus disease develops in less than 1% of infected individuals, with a mortality rate of approximately 9%. This scientific research aimed to analyze the epidemiological, clinical, and laboratory characteristics, the presence of comorbidities, and the treatme...

Full description

Saved in:
Bibliographic Details
Published inMedicinski pregled Vol. 77; no. 1-2; pp. 31 - 35
Main Authors Prastalo, Danijela, Boljanovic, Vanja, Petric, Vedrana, Djukic, Tijana, Bulovic, Aleksandra, Sevic, Sinisa
Format Journal Article
LanguageEnglish
Published 2024
Online AccessGet full text
ISSN0025-8105
1820-7383
DOI10.2298/MPNS2402031P

Cover

Abstract Introduction. Neuroinvasive the West Nile virus disease develops in less than 1% of infected individuals, with a mortality rate of approximately 9%. This scientific research aimed to analyze the epidemiological, clinical, and laboratory characteristics, the presence of comorbidities, and the treatment outcome of West Nile encephalitis in 2021 and 2022. Material and Methods. The retrospective study includes 33 patients treated at the Infectious Diseases Clinic of the University Clinical Center of Vojvodina from January 1, 2021 to December 31, 2022. The diagnosis was confirmed by serological tests and/or real-time reverse transcriptase polymerase chain reaction of cerebrospinal fluid. Results. The study demonstrated a statistically significant predominance of males (57.6%) over females (42.4%) (?2=4.5; p=0.03).Individuals over the age of 65 accounted for 51.52% of cases, with the remaining 48.48% being within the working-age population. The highest concentration of cases was observed in the Novi Sad (24.2%). Upon admission, elevated body temperature was prevalent 97% of patients (?2 = 8.8; p = 0.03), followed by weakness and malaise in 75.8%, and altered consciousness in 66.7%. Meningeal signs were present in only 48% of patients. Infection was confirmed in all patients through serological analysis of cerebrospinal fluid. A fatal outcome was observed in 31.3% of cases. Conclusion. The results of the research indicate that serological analysis is the most reliable method for diagnosing the neuroinvasive form of infection.
AbstractList Introduction. Neuroinvasive the West Nile virus disease develops in less than 1% of infected individuals, with a mortality rate of approximately 9%. This scientific research aimed to analyze the epidemiological, clinical, and laboratory characteristics, the presence of comorbidities, and the treatment outcome of West Nile encephalitis in 2021 and 2022. Material and Methods. The retrospective study includes 33 patients treated at the Infectious Diseases Clinic of the University Clinical Center of Vojvodina from January 1, 2021 to December 31, 2022. The diagnosis was confirmed by serological tests and/or real-time reverse transcriptase polymerase chain reaction of cerebrospinal fluid. Results. The study demonstrated a statistically significant predominance of males (57.6%) over females (42.4%) (?2=4.5; p=0.03).Individuals over the age of 65 accounted for 51.52% of cases, with the remaining 48.48% being within the working-age population. The highest concentration of cases was observed in the Novi Sad (24.2%). Upon admission, elevated body temperature was prevalent 97% of patients (?2 = 8.8; p = 0.03), followed by weakness and malaise in 75.8%, and altered consciousness in 66.7%. Meningeal signs were present in only 48% of patients. Infection was confirmed in all patients through serological analysis of cerebrospinal fluid. A fatal outcome was observed in 31.3% of cases. Conclusion. The results of the research indicate that serological analysis is the most reliable method for diagnosing the neuroinvasive form of infection.
Author Prastalo, Danijela
Djukic, Tijana
Sevic, Sinisa
Boljanovic, Vanja
Petric, Vedrana
Bulovic, Aleksandra
Author_xml – sequence: 1
  givenname: Danijela
  orcidid: 0009-0004-0584-7769
  surname: Prastalo
  fullname: Prastalo, Danijela
  organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad
– sequence: 2
  givenname: Vanja
  orcidid: 0009-0001-7287-532X
  surname: Boljanovic
  fullname: Boljanovic, Vanja
  organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad
– sequence: 3
  givenname: Vedrana
  orcidid: 0000-0001-5948-4140
  surname: Petric
  fullname: Petric, Vedrana
  organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad + University of Novi Sad, Faculty of Medicine, Novi Sad
– sequence: 4
  givenname: Tijana
  orcidid: 0009-0005-7252-6241
  surname: Djukic
  fullname: Djukic, Tijana
  organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad
– sequence: 5
  givenname: Aleksandra
  orcidid: 0009-0004-3636-5949
  surname: Bulovic
  fullname: Bulovic, Aleksandra
  organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad
– sequence: 6
  givenname: Sinisa
  orcidid: 0009-0009-3267-1195
  surname: Sevic
  fullname: Sevic, Sinisa
  organization: University Clinical Center of Vojvodina, Infectious Diseases Clinic, Novi Sad + University of Novi Sad, Faculty of Medicine, Novi Sad
BookMark eNpNkM1KAzEUhYNUsK3ufIA8gKP3JvOTWZaiVqi1YNHlkEkyTMp0MiRpwbe3gwquzuJ851ucGZn0rjeE3CLcM1aKh9ft5p2lwIDj9oJMUTBICi74hEwBWJYIhOyKzELYA-SYg5iSbtlKL1U03oZoVaCuoZ8mRLqxnaGmV2ZoZWejDdT2NLaGLo7R9e7gjoFuvTvZMzKOPtz-5LTt5R83nJVOUwYMaXRjsmty2cgumJvfnJPd0-NuuUrWb88vy8U6UUU2JGVdgzYSS1MXOULKU2QsyxVyQM6x0ZlSQmtVZ6xUhTy3vM4bUae8AcV0yufk7kervAvBm6YavD1I_1UhVONR1f-j-Dfr_VzN
Cites_doi 10.1007/978-3-7091-0572-6_4
10.1371/journal.pntd.0002184
10.1007/s00406-011-0222-6
10.1093/cid/ciaa749
10.1089/088282403322396082
10.1016/j.femsle.2004.01.035
10.1016/S0140-6736(98)03538-7
10.1016/B978-0-7020-3468-8.50052-3
10.1146/annurev.med.57.121304.131418
10.3201/eid0903.020628
10.3201/eid1108.050289b
10.3201/eid1207.060164
10.1089/vbz.2010.0206
10.2298/VSP140718115S
10.2807/1560-7917.ES.2021.26.19.2001095
10.4269/ajtmh.2005.72.768
10.1038/nm1140
10.3201/eid1905.121418
10.1089/153036604773083004
10.3201/eid1812.111208
10.1111/1469-0691.12211
10.2298/MPNS1604093H
10.1201/9780429289200-3
10.2807/1560-7917.ES2013.18.43.20613
10.4103/ijmr.IJMR_642_19
10.15585/mmwr.mm7118a3
10.1001/jama.290.4.511
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.2298/MPNS2402031P
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1820-7383
EndPage 35
ExternalDocumentID 10_2298_MPNS2402031P
GroupedDBID 2WC
53G
53S
5GY
AAYXX
ABDBF
ACUHS
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
DU5
EBD
EMOBN
EN8
EOJEC
ESX
F5P
IAO
IHR
INR
KQ8
MK0
OBODZ
OK1
PV9
RNS
RZL
SV3
TUS
~8M
ID FETCH-LOGICAL-c75p-9bb0dea19eb761043412256c1301331fd5cc8ddcb529c7a4123b6f8b43f0c2d43
ISSN 0025-8105
IngestDate Tue Jul 01 02:45:35 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1-2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c75p-9bb0dea19eb761043412256c1301331fd5cc8ddcb529c7a4123b6f8b43f0c2d43
ORCID 0000-0001-5948-4140
0009-0001-7287-532X
0009-0004-0584-7769
0009-0005-7252-6241
0009-0009-3267-1195
0009-0004-3636-5949
OpenAccessLink https://doi.org/10.2298/mpns2402031p
PageCount 5
ParticipantIDs crossref_primary_10_2298_MPNS2402031P
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-00-00
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024-00-00
PublicationDecade 2020
PublicationTitle Medicinski pregled
PublicationYear 2024
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref1
– ident: ref4
  doi: 10.1007/978-3-7091-0572-6_4
– ident: ref14
  doi: 10.1371/journal.pntd.0002184
– ident: ref25
  doi: 10.1007/s00406-011-0222-6
– ident: ref24
  doi: 10.1093/cid/ciaa749
– ident: ref6
  doi: 10.1089/088282403322396082
– ident: ref8
  doi: 10.1016/j.femsle.2004.01.035
– ident: ref19
  doi: 10.1016/S0140-6736(98)03538-7
– ident: ref2
  doi: 10.1016/B978-0-7020-3468-8.50052-3
– ident: ref3
  doi: 10.1146/annurev.med.57.121304.131418
– ident: ref5
  doi: 10.3201/eid0903.020628
– ident: ref11
  doi: 10.3201/eid1108.050289b
– ident: ref16
  doi: 10.3201/eid1207.060164
– ident: ref21
  doi: 10.1089/vbz.2010.0206
– ident: ref18
  doi: 10.2298/VSP140718115S
– ident: ref23
  doi: 10.2807/1560-7917.ES.2021.26.19.2001095
– ident: ref10
  doi: 10.4269/ajtmh.2005.72.768
– ident: ref7
  doi: 10.1038/nm1140
– ident: ref20
  doi: 10.3201/eid1905.121418
– ident: ref15
  doi: 10.1089/153036604773083004
– ident: ref27
  doi: 10.3201/eid1812.111208
– ident: ref13
  doi: 10.1111/1469-0691.12211
– ident: ref17
  doi: 10.2298/MPNS1604093H
– ident: ref12
  doi: 10.1201/9780429289200-3
– ident: ref26
  doi: 10.2807/1560-7917.ES2013.18.43.20613
– ident: ref28
  doi: 10.4103/ijmr.IJMR_642_19
– ident: ref22
  doi: 10.15585/mmwr.mm7118a3
– ident: ref9
  doi: 10.1001/jama.290.4.511
SSID ssj0061608
Score 2.2774
Snippet Introduction. Neuroinvasive the West Nile virus disease develops in less than 1% of infected individuals, with a mortality rate of approximately 9%. This...
SourceID crossref
SourceType Index Database
StartPage 31
Title Characteristics of West Nile encephalitis in the Autonomous Province of Vojvodina in the period 2021 to 2022
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVEJcEE8BBbQHOFUG7_qx9jFtqSqkVJEIVW_RvgJ2LTtqHA79F_xjZrJex0Q9FC52tA9byXyZ-fbx7RDywWibScHyINYJDFDizAZKCx7oLJSAIIigIQqcpxfp-ff461VyNRr9Huxa2rTqk769U1fyP1aFMrArqmT_wbL9Q6EAPoN94QoWhuu9bHyyd9oyED_MFAPmrewR_mVXP5FmF2u_m3GyaVHEgNteZ9u5BL2dMrhsyl8NBDHp2-Hxx4054hCakZzCnQ9Z7NQtyK-vCzxj4EfVCaTQw97INc4HefV6aavdiL-pSlnDW7dJ1S9lXcqdY8ZEAdtiayB69hWn5ebaVcyL0pd3kxROFd3LBZIgY6FburbOywLtCETkMth4N9xlcyn-0kQ6r9rFCRef3ekm-56f8xzVDNPZxTdcLwJXNdtFOL-qvxf4-u2IMBDC_oth7wfkgAvB4jE5mByfHp_58J6yNMx8HmD8Xk5Ngf0_D_sPeM6AsMyfkMfdSINOHGyekpGtn5GHnensc1LtoYc2S4rooYgeOkQPLWoKqKA79FCPHuzUo8e3c-ihiB7aNnjnL8j87Mv85Dzocm8EWiSrIFcqNFay3CoBBDsGrgOOP9XAeFgUsaVJtM6M0SrhuRYSaiOVLjMVR8tQcxNHL8m4bmr7ilALBFaxxHIr8Ckqi1hijNIJF3FqmHpNPvofarFyJ6ws7jLIm3u2OySPEIFumuwtGbc3G_sOiGOr3nem_AP4z22U
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characteristics+of+West+Nile+encephalitis+in+the+Autonomous+Province+of+Vojvodina+in+the+period+2021+to+2022&rft.jtitle=Medicinski+pregled&rft.au=Prastalo%2C+Danijela&rft.au=Boljanovic%2C+Vanja&rft.au=Petric%2C+Vedrana&rft.au=Djukic%2C+Tijana&rft.date=2024&rft.issn=0025-8105&rft.eissn=1820-7383&rft.volume=77&rft.issue=1-2&rft.spage=31&rft.epage=35&rft_id=info:doi/10.2298%2FMPNS2402031P&rft.externalDBID=n%2Fa&rft.externalDocID=10_2298_MPNS2402031P
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-8105&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-8105&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-8105&client=summon